norethindrone acetate has been researched along with Atrophy in 3 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moyer, DL | 1 |
| Felix, JC | 1 |
| Hillard, TC | 1 |
| Siddle, NC | 1 |
| Whitehead, MI | 1 |
| Fraser, DI | 1 |
| Pryse-Davies, J | 1 |
| Staland, B | 1 |
3 other studies available for norethindrone acetate and Atrophy
| Article | Year |
|---|---|
The effects of progesterone and progestins on endometrial proliferation.
Topics: Atrophy; Biopsy; Cell Division; Contraceptives, Oral; Cyclins; Endometrium; Female; Humans; Medroxyp | 1998 |
Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis.
Topics: Amenorrhea; Atrophy; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Female; H | 1992 |
Continuous treatment with a combination of estrogen and gestagen--a way of avoiding endometrial stimulation. Clinical experiences with Kliogest.
Topics: Atrophy; Climacteric; Drug Combinations; Endometrium; Estradiol; Estriol; Female; Humans; Menopause; | 1985 |